Leaders | Green protectionism

How the EU should respond to American subsidies

Instead of imitating them, it should play to its strengths

21 February 2023, Mecklenburg-Western Pomerania, Rostock: A hub for the turbine of a 6 MW class wind turbine is being worked on at Nordex Energy. A ceremony marks the official start of series production at Nordex of the 6 MW class turbines, the company's most powerful large turbine. Photo: Bernd Wüstneck/dpa
Image: dpa

This year the European Union will celebrate a momentous achievement: its single market turns 30. The unfettered movement of goods, people, services and money within the bloc, together with an openness to foreign trade and investment, has served the eu remarkably well. But, among the leaders of member countries who had gathered in Brussels to talk about the single market as The Economist was published, the mood was more anxious than jubilant. There is a nagging fear that the eu’s economic model may no longer be working.

This article appeared in the Leaders section of the print edition under the headline “Play to your strengths ”

From the March 25th 2023 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights